![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Expands Indication of Levita’s Magnetic Surgical System
FDA Expands Indication of Levita’s Magnetic Surgical System
October 22, 2018
Levita Magnetics received FDA clearance for an expanded indication of its magnetic surgical system for use in bariatric procedures.
The shaftless device — an external magnet placed on the skin that controls a detachable grasper — was originally indicated for gallbladder removal procedures, and can now reduce the amount of incisions and trocars needed in bariatric procedures.
The Levita System enables surgeons to move instruments without being restricted by a fixed-position pivot point and improves their visualization of the surgical site.
Upcoming Events
-
21Oct